10 August 2022
US EPA about to approve Amoéba’s biocide for use in closed cooling systems
Amoéba informs that the US EPA has made a positive pre-decisional determination for the use of Amoéba’s biocide in closed cooling systems.
13 June 2022
Amoéba : Issuance of the 5th tranche of OCA
Amoéba announces the issuance of the fifth tranche of 60 bonds convertible into shares as part of its new bond financing with incentive program with Nice & Green S.A.
30 May 2022
Amoéba: US regulatory calendar update
Amoeba announces that the US EPA, in charge of the evaluation of the biocide and biocontrol applications in the United States, has requested an extension of the assessment period : the conclusions should now be available in the second half of 2022.
6 May 2022
Ordinary and extraordinary general meeting to be held on 24 May 2022
Amoéba announces the availability of preparatory documents for the General Assembly of May 24, 2022
3 May 2022
Amoeba: Malta recommends the non-approval of the “biocide” active substance for the European territory
Amoeba announces that the Maltese authority recommends the non-approval of the biocidal active substance for the European territory
25 April 2022
Amoéba: Austria recommends the approval of the biocontrol application in Europe
Amoéba announces that AGES, in charge of the application for approval of the biocontrol active substance “Lysate of Willaertia magna C2c Maky”, recommends its approval for use in plant protection on the European territory.
13 April 2022
Amoéba : Publication of the 2021 Universal Registration Document
Amoéba announces that the 2021 Universal Registration Document was filed with the French Financial Markets Authority (Autorité des marchés financiers AMF) on April 12, 2022.
5 April 2022
Amoéba : Deferral of the 5th tranche of OCAs
Amoéba announces having exercised the suspension option relating to the issuance of the 5th tranche of OCAs, initially scheduled for April 5, 2022.
25 March 2022
Update of the European regulatory application calendar
Amoéba announces a report of the conclusion of the evaluation of the European biocide and biocontrol dossiers.
24 August 2021
Results of the 2nd cereal trial campaign
Amoeba confirms its biocontrol’s effectiveness against major cereal diseases
29 July 2021
Promising results of the Biocontrol-Grapewine application
Amoéba announces the results of the field trials 3rd campaign on grapes
5 July 2021
Postponement of the biocide active substance dossier
Malta commits to finalize the report in the 4th quarter of 2021
24 June 2021
Appointment of Philippe Dujardin to the Board of Directors
Philippe Dujardin replaces Pascal Reber as independent director
2 June 2021
General Meeting of June 24, 2021
Availability of the preparatory documents for the General meeting of 27 may 2021
27 May 2021
General Meeting second convocation
Due to a lack of quorum, the General Meeting is postponed to June 24, 2021
10 May 2021
General Assembly of May 27, 2021
Amoéba provides shareholders with preparatory documents
6 April 2021
Submission of the biocide application in the USA
Amoéba has submitted the application for approval of the biocidal active substance
6 April 2021
Massive new field trials campaign
Amoeba continues testing its biocontrol product in 2021
26 March 2021
Amoéba announces the 2020 financial year results
marked by the continued development of its biocidal and biocontrol applications
12 March 2021
Research partnership with the US group GOWAN COMPANY
Amoéba extends to the U.S.A. the testing of its biocontrol
10 March 2021
Appointment of Pierre Morgon to the Board of Directors
Amoéba has appointed Pierre Morgon as censor.
10 March 2021
Development and commercialization agreement
Signature of a Letter of Intent (LOI) with PHILAGRO France
18 December 2020
Signature of a non-exclusive development and marketing agreement
in Switzerland with Stähler for its vine Bioncontrol product.